Clinical Trial Update: A Clinical Evaluation on Traditional Chinese Medicine Diagnosis and Treatment Program Blocking and Reversing Hepatitis B-related Liver Fibrosis - a Randomized, Controlled, Double-blind, Multi-center Clinical Trial [Phase 4]

View source ↗

Summary

A Phase 4 randomized, double-blind, multi-center trial evaluates a traditional Chinese medicine diagnosis and treatment program to block and reverse Hepatitis B…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Liver Fibrosis

Snippet

Sponsor: Beijing 302 Hospital | Conditions: Liver Fibrosis, Chronic Hepatitis B | Phase 4 | Status: UNKNOWN